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Aperio analysis confirms absence of e-cadherin as
potential marker for recurrent disease

Introduction
Oral cancer is the eleventh most common
cancer worldwide (WHO)
· Pakistan has one of the highest incidence of
oral cancer in the world
· Approximately 20-30% of patients with early
oral tongue carcinoma will have occult neck
nodal modal metastasis
· Presently, elective neck dissection remains the
only reliable way to predict regional and or
distant metastasis
· There has been an influx of studies to
determine if biomarkers, both genetic and
proteomic of oral cancers diagnosis, prognosis,
and metastatic potential

·

Experimental Aim
Signature proteins will constitute new markers for
predicted of nodal metastasis in the form of
potential biomarker panel in SCCOT
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Methods

The graph above depicts the levels of E-Cadherin of the normal vs. metastasized
cells. Metastasized cells show lower levels of E-Cadherin in comparison to the
normal cells and suggest E-Cadherin as a possible biomarker for oral cancer.
A tissue microarray was used to analyze the samples. Multiple cores from each patient sample was placed on a slide glass and analyzed one time instead
of individually.
A tissue microarray was used to analyze the samples. Multiple cores from each patient sample was placed on a slide glass and analyzed one time instead of individually.

Podoplanin results were not confirmed through Aperio analysis

Retrospective analysis was performed in a doubleblind manner on tissues microarray (5
cores/patient) created from paraffin-embedded
specimens from 50 patients with well documented
clinical history of the disease. A subset of 20
different proteins were elected as potential
biomarkers of metastasis based on published
literature on SCCOT and analyzed through
immunohistochemistry. Three proteins, E-cadherin,
Podoplanin, and Microglobulin were found as
possible predicators of metastasis. These findings
were validated using Aperio image analysis
software.

• Data review of Podoplanin revealed
incorrect section choices. Need to rescore
by Aperio using correct area matching tumor
tissue histology results.
• E-cadherin data analysis confirmed its importance in
maintaining normal behavior of cells through cell-cell
and cell-matrix interactions.

Future Directions
Need to confirm analyses for Beta
2 microglobulin and repeat Podoplanin analysis.

TMA-1
A tissue microarray was used to
analyze the samples. Multiple cores
from each patient sample was
placed on a slide glass and analyzed
one time instead of individually.

Importance of area selection in Aperio analysis

Clinical Relevance
After Aperio analysis, it can be shown by that graph that there is no significance to support any conclusion that
podoplanin is a biomarker for oral cancer. Further research is needed to develop new significant findings.

These results can help in translating these markers
to clinical practice in order to examine how the
disease progresses.

